These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1194825)

  • 1. Properties of antisera against synthetic 1--34 human parathyroid hormone.
    Visser TJ; Buurman CJ; Hackeng WH; Birkenhäger JC
    J Endocrinol; 1975 Oct; 67(1):141-2. PubMed ID: 1194825
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-34 Human parathyroid hormone radioimmunoassay: properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application.
    Shiraki M; Kawada N; Akiguchi I; Yamauchi H; Kojima A; Orimo H
    Endocrinol Jpn; 1981 Apr; 28(2):239-44. PubMed ID: 7308159
    [No Abstract]   [Full Text] [Related]  

  • 3. Production and characterization of antisera to synthetic 1-34 human parathyroid hormone fragments: possible implications for the correctness of proposed structures.
    Visser TJ; Buurman CJ; Birkenhäger JC
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):90-102. PubMed ID: 760361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological studies on parathyroid hormone: characterization of antisera against synthetic 1-34 human parathyroid hormone and evidence that position 30 in human parathyroid hormone is aspartic acid.
    Visser TJ; Buurman CJ; Birkenhäger JC
    J Endocrinol; 1977 Sep; 74(3):461-6. PubMed ID: 925571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parathyroid hormone: immunological properties of the amino terminus and of synthetic fragments.
    Hendy GN; Barling PM; O'Riordan JL
    Clin Sci Mol Med; 1974 Dec; 47(6):567-76. PubMed ID: 4476267
    [No Abstract]   [Full Text] [Related]  

  • 6. Cleavage-associated enhancement of an antigenic site in the biologically active NH2-terminal region of parathyroid hormone.
    Habener JF; Potts JT
    Endocrinology; 1979 Jul; 105(1):115-9. PubMed ID: 87321
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological properties of synthetic human parathyroid hormone: effect of deamidation at position 76.
    Gleed JH; Hendy GN; Kimura T; Sakakibara S; O'Riordan JL
    Bone Miner; 1987 Aug; 2(5):375-82. PubMed ID: 2464379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large scale screening programme for selection of antisera for radioimmunoassay of human parathyroid hormone.
    Zanelli JM; Rafferty B; Apostolou B; Court G; Hurn BA
    J Immunoassay; 1983; 4(2):175-206. PubMed ID: 6886015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Immunological properties of a synthetic 1-34 fragment of human parathyroid hormone.
    Hendy GN; Barling PM; O'Riordan JL
    J Endocrinol; 1974 Nov; 63(2):26P-27P. PubMed ID: 4443686
    [No Abstract]   [Full Text] [Related]  

  • 10. Human parathyroid hormone: antibody characterization.
    Hehrmann R; Nordmeyer JP; Mohr H; Hesch RD
    J Immunoassay; 1980; 1(2):151-74. PubMed ID: 7229044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the binding sites of anti-parathyroid hormone antisera using synthetic parathyroid hormone peptides.
    Atkinson MJ; Jüppner H; Niepel B; Casaretto M; Zahn H; Hesch RD
    J Immunoassay; 1982; 3(1):31-51. PubMed ID: 7130399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of circulating immunoreactive human parathyroid hormone: comparison with a 1-34 N-terminal synthetic fragment.
    Desplan C; Jullienne A; Moukhtar MS; Raulais D; Rivaille P; Milhaud G
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):241-4. PubMed ID: 622389
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological properties of synthetic human parathyroid hormone 53--84 fragment.
    Hendy GN; Manning RM; Rosenblatt M; Tregear GW; Keutmann HT; O'Riordan JL
    J Endocrinol; 1979 Jan; 80(1):153-5. PubMed ID: 429948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for parathyrin. Characterization of six different antigens and antisera.
    Voll R; Schmidt-Gayk H; Wiedeman J; Hüfner M; Bouillon R; Keutmann H; Hehrmann R
    J Clin Chem Clin Biochem; 1978 May; 16(5):269-77. PubMed ID: 566781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassays for the 28-48 region of parathyroid hormone detect intact hormone but not hormone fragments.
    Mallette LE; Renfro M; Lemoncelli J; Rosenblatt M
    Calcif Tissue Int; 1981; 33(4):375-80. PubMed ID: 6794876
    [No Abstract]   [Full Text] [Related]  

  • 16. A new radioimmunoassay for the midregion of canine parathyroid hormone.
    Mallette LE; Tuma SN
    Miner Electrolyte Metab; 1984; 10(1):43-7. PubMed ID: 6738461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct release of parathyroid hormone fragments from functioning bovine parathyroid glands in vitro.
    Hanley DA; Takatsuki K; Sultan JM; Schneider AB; Sherwood LM
    J Clin Invest; 1978 Dec; 62(6):1247-54. PubMed ID: 748378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tests on three antisera and subsequent development of radioimmunoassay for different regions of human parathyrin.
    Wood WG; Marschner I; Scriba PC
    Horm Metab Res; 1979 Apr; 11(4):309-17. PubMed ID: 88403
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological comparisons of two synthetic human parathyroid hormone-(1-34) peptides.
    Segre GV; Potts JT
    Endocrinology; 1976 May; 98(5):1294-301. PubMed ID: 57054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of human parathyroid hormone (28-48): attempt to develop an assay for intact human parathyroid hormone.
    Mallette LE
    Metab Bone Dis Relat Res; 1983; 4(6):329-32. PubMed ID: 6664305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.